• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SUMO化修饰在酵母细胞和胰腺导管腺癌细胞中均能调节真核翻译起始因子5A(eIF5A)的活性。

SUMOylation modulates eIF5A activities in both yeast and pancreatic ductal adenocarcinoma cells.

作者信息

Seoane Rocío, Lama-Díaz Tomás, Romero Antonia María, El Motiam Ahmed, Martínez-Férriz Arantxa, Vidal Santiago, Bouzaher Yanis H, Blanquer María, Tolosa Rocío M, Castillo Mewa Juan, Rodríguez Manuel S, García-Sastre Adolfo, Xirodimas Dimitris, Sutherland James D, Barrio Rosa, Alepuz Paula, Blanco Miguel G, Farràs Rosa, Rivas Carmen

机构信息

Centro de Investigación en Medicina Molecular (CIMUS), IDIS, Universidade de Santiago de Compostela, Avda Barcelona, 15706, Santiago de Compostela, Spain.

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

出版信息

Cell Mol Biol Lett. 2024 Jan 16;29(1):15. doi: 10.1186/s11658-024-00533-5.

DOI:10.1186/s11658-024-00533-5
PMID:38229033
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10790418/
Abstract

BACKGROUND

The eukaryotic translation initiation protein eIF5A is a highly conserved and essential factor that plays a critical role in different physiological and pathological processes including stress response and cancer. Different proteomic studies suggest that eIF5A may be a small ubiquitin-like modifier (SUMO) substrate, but whether eIF5A is indeed SUMOylated and how relevant is this modification for eIF5A activities are still unknown.

METHODS

SUMOylation was evaluated using in vitro SUMOylation assays, Histidine-tagged proteins purification from His6-SUMO2 transfected cells, and isolation of endogenously SUMOylated proteins using SUMO-binding entities (SUBES). Mutants were engineered by site-directed mutagenesis. Protein stability was measured by a cycloheximide chase assay. Protein localization was determined using immunofluorescence and cellular fractionation assays. The ability of eIF5A1 constructs to complement the growth of Saccharomyces cerevisiae strains harboring thermosensitive mutants of a yeast EIF5A homolog gene (HYP2) was analyzed. The polysome profile and the formation of stress granules in cells expressing Pab1-GFP (a stress granule marker) by immunofluorescence were determined in yeast cells subjected to heat shock. Cell growth and migration of pancreatic ductal adenocarcinoma PANC-1 cells overexpressing different eIF5A1 constructs were evaluated using crystal violet staining and transwell inserts, respectively. Statistical analysis was performed with GraphPad Software, using unpaired Student's t-test, or one-way or two-way analysis of variance (ANOVA).

RESULTS

We found that eIF5A is modified by SUMO2 in vitro, in transfected cells and under endogenous conditions, revealing its physiological relevance. We identified several SUMO sites in eIF5A and found that SUMOylation modulates both the stability and the localization of eIF5A in mammalian cells. Interestingly, the SUMOylation of eIF5A responds to specific stresses, indicating that it is a regulated process. SUMOylation of eIF5A is conserved in yeast, the eIF5A SUMOylation mutants are unable to completely suppress the defects of HYP2 mutants, and SUMOylation of eIF5A is important for both stress granules formation and disassembly of polysomes induced by heat-shock. Moreover, mutation of the SUMOylation sites in eIF5A abolishes its promigratory and proproliferative activities in PANC-1 cells.

CONCLUSIONS

SUMO2 conjugation to eIF5A is a stress-induced response implicated in the adaptation of yeast cells to heat-shock stress and required to promote the growth and migration of pancreatic ductal adenocarcinoma cells.

摘要

背景

真核生物翻译起始蛋白eIF5A是一种高度保守且必不可少的因子,在包括应激反应和癌症在内的不同生理和病理过程中发挥关键作用。不同的蛋白质组学研究表明,eIF5A可能是一种小泛素样修饰物(SUMO)底物,但eIF5A是否真的被SUMO化以及这种修饰与eIF5A活性的相关性仍不清楚。

方法

使用体外SUMO化测定、从His6-SUMO2转染细胞中纯化组氨酸标签蛋白以及使用SUMO结合实体(SUBES)分离内源性SUMO化蛋白来评估SUMO化。通过定点诱变构建突变体。通过环己酰亚胺追踪测定法测量蛋白质稳定性。使用免疫荧光和细胞分级分离测定法确定蛋白质定位。分析了eIF5A1构建体对携带酵母EIF5A同源基因(HYP2)热敏突变体的酿酒酵母菌株生长的互补能力。通过免疫荧光测定了在热休克的酵母细胞中表达Pab1-GFP(一种应激颗粒标记物)的细胞中的多核糖体谱和应激颗粒的形成。分别使用结晶紫染色和Transwell小室评估过表达不同eIF5A1构建体的胰腺导管腺癌PANC-1细胞的细胞生长和迁移。使用GraphPad软件进行统计分析,采用不成对学生t检验或单因素或双因素方差分析(ANOVA)。

结果

我们发现eIF5A在体外、转染细胞中和内源性条件下都被SUMO2修饰,揭示了其生理相关性。我们在eIF5A中鉴定了几个SUMO位点,发现SUMO化调节了eIF5A在哺乳动物细胞中的稳定性和定位。有趣的是,eIF5A的SUMO化对特定应激有反应,表明它是一个受调控的过程。eIF5A的SUMO化在酵母中是保守的,eIF5A SUMO化突变体无法完全抑制HYP2突变体的缺陷,并且eIF5A的SUMO化对于热休克诱导的应激颗粒形成和多核糖体解体都很重要。此外,eIF5A中SUMO化位点的突变消除了其在PANC-1细胞中的促迁移和促增殖活性。

结论

SUMO2与eIF5A的缀合是一种应激诱导反应,与酵母细胞对热休克应激的适应有关,并且是促进胰腺导管腺癌细胞生长和迁移所必需的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ff/10790418/3b380c322418/11658_2024_533_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ff/10790418/21c2aec8bd58/11658_2024_533_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ff/10790418/c27cd37738f7/11658_2024_533_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ff/10790418/0fbd0a605792/11658_2024_533_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ff/10790418/a772ce5f4775/11658_2024_533_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ff/10790418/0e23da8a3e12/11658_2024_533_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ff/10790418/810aecfa2405/11658_2024_533_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ff/10790418/fbada51c2a5b/11658_2024_533_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ff/10790418/92741cd4182f/11658_2024_533_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ff/10790418/3b380c322418/11658_2024_533_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ff/10790418/21c2aec8bd58/11658_2024_533_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ff/10790418/c27cd37738f7/11658_2024_533_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ff/10790418/0fbd0a605792/11658_2024_533_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ff/10790418/a772ce5f4775/11658_2024_533_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ff/10790418/0e23da8a3e12/11658_2024_533_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ff/10790418/810aecfa2405/11658_2024_533_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ff/10790418/fbada51c2a5b/11658_2024_533_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ff/10790418/92741cd4182f/11658_2024_533_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ff/10790418/3b380c322418/11658_2024_533_Fig9_HTML.jpg

相似文献

1
SUMOylation modulates eIF5A activities in both yeast and pancreatic ductal adenocarcinoma cells.SUMO化修饰在酵母细胞和胰腺导管腺癌细胞中均能调节真核翻译起始因子5A(eIF5A)的活性。
Cell Mol Biol Lett. 2024 Jan 16;29(1):15. doi: 10.1186/s11658-024-00533-5.
2
SUMO-Binding Entities (SUBEs) as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer.SUMO结合实体(SUBEs)作为富集、分离、鉴定和表征肝癌中SUMO蛋白质组的工具
J Vis Exp. 2019 Nov 1(153). doi: 10.3791/60098.
3
Proteome-wide analysis of SUMO2 targets in response to pathological DNA replication stress in human cells.人类细胞中响应病理性DNA复制应激的SUMO2靶标的全蛋白质组分析。
DNA Repair (Amst). 2015 Jan;25:84-96. doi: 10.1016/j.dnarep.2014.10.011. Epub 2014 Nov 25.
4
Methods to study SUMO dynamics in yeast.研究酵母中SUMO动态变化的方法。
Methods Enzymol. 2019;618:187-210. doi: 10.1016/bs.mie.2018.12.026. Epub 2019 Feb 11.
5
SUMOylation and the HSF1-Regulated Chaperone Network Converge to Promote Proteostasis in Response to Heat Shock.SUMOylation 和热休克因子 1 调节的伴侣蛋白网络的汇聚促进热休克后的蛋白质稳态。
Cell Rep. 2019 Jan 2;26(1):236-249.e4. doi: 10.1016/j.celrep.2018.12.027.
6
Analysis of Ubiquitylation and SUMOylation of Yeast Nuclear Pore Complex Proteins.酵母核孔复合体蛋白的泛素化和类泛素化修饰分析
Methods Mol Biol. 2022;2502:259-269. doi: 10.1007/978-1-0716-2337-4_17.
7
Small ubiquitin-like modifier 3-modified proteome regulated by brain ischemia in novel small ubiquitin-like modifier transgenic mice: putative protective proteins/pathways.新型小泛素样修饰物转基因小鼠中脑缺血调节的小泛素样修饰物3修饰蛋白质组:假定的保护蛋白/途径
Stroke. 2014 Apr;45(4):1115-22. doi: 10.1161/STROKEAHA.113.004315. Epub 2014 Feb 25.
8
Identification of Substrates of Protein-Group SUMOylation.蛋白质组SUMO化修饰底物的鉴定
Methods Mol Biol. 2016;1475:219-31. doi: 10.1007/978-1-4939-6358-4_16.
9
SUMO is a pervasive regulator of meiosis.SUMO 是一种普遍存在的减数分裂调节因子。
Elife. 2021 Jan 27;10:e57720. doi: 10.7554/eLife.57720.
10
Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies.抑制泛素化会导致 SUMO 化的新合成核蛋白在 PML 体中积累。
J Biol Chem. 2019 Oct 18;294(42):15218-15234. doi: 10.1074/jbc.RA119.009147. Epub 2019 Jul 8.

引用本文的文献

1
Stress granules in cancer: Adaptive dynamics and therapeutic implications.癌症中的应激颗粒:适应性动态变化及治疗意义
iScience. 2024 Jun 22;27(8):110359. doi: 10.1016/j.isci.2024.110359. eCollection 2024 Aug 16.
2
The role of polyamine metabolism in cellular function and physiology.多胺代谢在细胞功能和生理学中的作用。
Am J Physiol Cell Physiol. 2024 Aug 1;327(2):C341-C356. doi: 10.1152/ajpcell.00074.2024. Epub 2024 Jun 17.

本文引用的文献

1
High levels of hypusinated eIF5A in leiomyoma and leiomyosarcoma pathologies: a possible novel therapeutic target.高水平的 hypusinated eIF5A 在平滑肌瘤和平滑肌肉瘤病变中的表达:一种新的潜在治疗靶点。
Reprod Biomed Online. 2023 Jul;47(1):15-25. doi: 10.1016/j.rbmo.2023.03.017. Epub 2023 Mar 27.
2
Eukaryotic Initiation Factor 5A2 localizes to actively translating ribosomes to promote cancer cell protrusions and invasive capacity.真核起始因子 5A2 定位于正在翻译的核糖体上,以促进癌细胞突起和侵袭能力。
Cell Commun Signal. 2023 Mar 13;21(1):54. doi: 10.1186/s12964-023-01076-6.
3
The pleiotropic roles of eIF5A in cellular life and its therapeutic potential in cancer.
eIF5A 在细胞生命中的多功能作用及其在癌症治疗中的潜力。
Biochem Soc Trans. 2022 Dec 16;50(6):1885-1895. doi: 10.1042/BST20221035.
4
Stress Granules Determine the Development of Obesity-Associated Pancreatic Cancer.应激颗粒决定肥胖相关胰腺癌的发展。
Cancer Discov. 2022 Aug 5;12(8):1984-2005. doi: 10.1158/2159-8290.CD-21-1672.
5
Role of eIF5A in Mitochondrial Function.eIF5A 在线粒体功能中的作用。
Int J Mol Sci. 2022 Jan 24;23(3):1284. doi: 10.3390/ijms23031284.
6
Waves of sumoylation support transcription dynamics during adipocyte differentiation.SUMOylation 波支持脂肪细胞分化过程中的转录动力学。
Nucleic Acids Res. 2022 Feb 22;50(3):1351-1369. doi: 10.1093/nar/gkac027.
7
Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model.TAK-981 通过靶向胰腺癌:一种 SUMOylation 抑制剂,在临床前模型中激活免疫系统并阻断癌细胞周期进程。
Gut. 2022 Nov;71(11):2266-2283. doi: 10.1136/gutjnl-2021-324834. Epub 2022 Jan 24.
8
The eukaryotic initiation factor 5A (eIF5A1), the molecule, mechanisms and recent insights into the pathophysiological roles.真核生物起始因子5A(eIF5A1):分子、机制以及对其病理生理作用的最新见解
Cell Biosci. 2021 Dec 24;11(1):219. doi: 10.1186/s13578-021-00733-y.
9
SUMO paralogue-specific functions revealed through systematic analysis of human knockout cell lines and gene expression data.通过系统分析人类敲除细胞系和基因表达数据揭示 SUMO 旁系同源物的特有功能。
Mol Biol Cell. 2021 Sep 1;32(19):1849-1866. doi: 10.1091/mbc.E21-01-0031. Epub 2021 Jul 7.
10
SUMO and Transcriptional Regulation: The Lessons of Large-Scale Proteomic, Modifomic and Genomic Studies.SUMO 与转录调控:大规模蛋白质组学、修饰组学和基因组学研究的启示。
Molecules. 2021 Feb 5;26(4):828. doi: 10.3390/molecules26040828.